
Please try another search
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process scale-up process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled syringes. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Name | Age | Since | Title |
---|---|---|---|
Ray Diradoorian | - | 2022 | Director |
Joshua E. Schechter | 51 | 2020 | Independent Director |
Katrina L. Houde | 66 | 2019 | Independent Chairman of the Board |
Paul Josephs | 59 | 2024 | President, CEO & Director |
Nelson Jay Obus | 77 | 2018 | Independent Director |
Paul H. Johnson | 66 | 2024 | Independent Director |
Matthew E. Korenberg | 49 | 2024 | Independent Director |
Humberto C. Antunes | 62 | 2024 | Independent Director |
Jason M. Aryeh | 56 | 2024 | Independent Director |
Christopher Sean Kiper | 53 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review